SCHEMBL3418456

SCHEMBL3418456

CC(C)(C)c1ccccc1OP(Oc1ccccc1C(C)(C)C)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.42
ATM Q13315 1/20 0.42
MAPT P10636 2/20 0.40
TP53 P04637 1/20 0.40
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 3/20 0.40
GAA P10253 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TSHR P16473 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
NISCH Q9Y2I1 1/20 0.36
RBP4 P02753 3/20 0.35
BCHE P06276 1/20 0.35
CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13199352 0.93 TDP1 (0.39) TDP1ATMMAPTTP53ALDH1A1
SCHEMBL8939054 0.87 MAPT (0.38) TDP1ATMMAPTTP53ALDH1A1
SCHEMBL31556872 0.86 TDP1 (0.36) TDP1ATMMAPTTP53ALDH1A1
SCHEMBL28363499 0.85 TDP1 (0.42) TDP1ATMMAPTTP53ALDH1A1
SCHEMBL8938990 0.84 CYP1A2 (0.40) TDP1ATMMAPTTP53ALDH1A1
SCHEMBL10309813 0.83 TDP1 (0.33) TDP1ATMMAPTTP53ALDH1A1
SCHEMBL8360217 0.82 CA2 (0.40) TDP1ATMALDH1A1KDM4EGAA
SCHEMBL27772030 0.81 NAMPT (0.44) TDP1ATMMAPTTP53ALDH1A1
SCHEMBL2368433 0.81 TDP1 (0.41) TDP1ATMMAPTTP53ALDH1A1
SCHEMBL7115234 0.81 APEX1 (0.39) TDP1MAPTALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851656-B2 Method for producing organic phosphorous compounds containing halogens BASF SE (DE) 2010-12-14 US disclosed
US-7851656-B2 Method for producing organic phosphorous compounds containing halogens BASF SE (DE) 2010-12-14 US disclosed
US-20100252786-A1 CELLULOSE ESTER FILM, METHOD OF MANUFACTURING THE SAME, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY KONICA MINOLTA OPTO, INC. (JP) 2010-10-07 US disclosed
US-20100103352-A1 OPTICAL FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY AND ULTRAVIOLET ABSORBING POLYMER KONICA MINOLTA OPTO, INC. (JP) 2010-04-29 US disclosed
US-20090281356-A1 METHOD FOR PRODUCING ORGANIC PHOSPHOROUS COMPOUNDS CONTAINING HALOGENE BASF SE (DE) 2009-11-12 US disclosed
US-20090281356-A1 METHOD FOR PRODUCING ORGANIC PHOSPHOROUS COMPOUNDS CONTAINING HALOGENE BASF SE (DE) 2009-11-12 US disclosed
WO-2008006735-A1 METHOD FOR PRODUCING ORGANIC PHOSPHOROUS COMPOUNDS CONTAINING HALOGENE BASF SE (DE) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281356-A1 METHOD FOR PRODUCING ORGANIC PHOSPHOROUS COMPOUNDS CONTAINING HALOGENE PRXL2A, XRN2, POLR2B TDP1 1546/4885ATM 3382/4885MAPT 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.